Hypodermic Syringes and Needles Market Size & Share 2025 - 2034

Hypodermic Syringes and Needles Market Size

The global hypodermic syringes and needles market was valued at USD 7.3 billion in 2024 and is expected to exhibit growth at a CAGR of 2.9% from 2025 to 2034, with the market estimated at USD 7.6 billion in 2025 and reaching USD 9.8 billion by 2034. The rapid market expansion is attributable to factors such as the increased prevalence of chronic diseases, the rise in surgeries performed, and the growing use of syringes and needles for blood collection, among others.

Diabetes, cardiovascular diseases, arthritis, and cancer are some chronic illnesses that are becoming prevalent globally. For this reason, greater medical attention is required, and most of these interventions are further managed with injections. For instance, the Centers for Disease Control and Prevention states that in 2021, over 38.4 million Americans were diagnosed with diabetes, a staggering 11.6% of the total population. There was also an additional 97.6 million citizens above 18 who were deemed 'prediabetic'.
 

 Technologically designed hypodermic syringes and needles have increased in popularity due to their necessity for most medications used today to track blood glucose and even offer life-saving therapies. With the unrivaled importance of these devices and many others, the escalation in demand has significantly advanced.
 

Additionally, chronic diseases often involve injective treatments as routine therapy. Diabetes patients need to take insulin injections, while later-stage rheumatoid arthritis patients are given biologics. These escalated levels of chronic disorders mean more injections will need to be given along with more hypodermic syringes as well as needles. For countless chronic conditions, injectable medications are incredibly efficient because they have a much quicker effect than oral alternatives.
 

Hypodermic needles and syringes are crucial in the medical field for administering or extracting fluids. Hypodermic needles are slim, hollow tubes with sharp tips meant to pierce the skin, while syringes are cylindrical devices with a barrel and plunger, usually attached to a needle, used to inject or draw out fluids in different medical treatments.
 

Hypodermic Syringes and Needles Market Trends

In the market of hypodermic syringes and needles, newer technologies and innovations have created growth opportunities as manufacturers produce better and safer devices to suit the needs of patients and healthcare providers.
 

• Retractable needles, needle shields, and auto-disable syringes which offer single-use functionality are some of the most important features that improve patient and health worker safety in hospitals and clinics. Using these syringes and needles can significantly lower the risk of needlestick injuries and contamination, creating a safer environment for healthcare workers. The demand for these products will grow as more individuals become aware of the safety concerns in busy places like hospitals and clinics.
   
• As for now, the trend towards self-injectable medications means that prefilled syringes and hypodermic needles will become common in healthcare provision due to their ease of use, accuracy, and lower chances of contamination. These have also greatly improved compliance from patients with chronic conditions such as Diabetes and Rheumatoid Arthritis who require constant injections. This trend also supports home-based healthcare and therefore has increased the demand for prefilled syringes and hypo needles.
   

Hypodermic Syringes and Needles Market Analysis

Based on type, the market is segmented as syringes and needles. The needles segment is expected to drive business growth and expand at a CAGR of 3.1%, reaching over USD 5.4 billion by 2034. Also, the global market was valued at USD 7.1 billion in 2023.
 

• Patients suffering from chronic illnesses like diabetes, arthritis, and some cardiovascular diseases usually need to use injectables which continuously increases the demand for hypodermic needles. Diabetes patients, for instance, depend on insulin delivery devices and glucose meters. This perpetual demand for chronic care explains why the needle segment boasts the largest market share, for needles are fundamental devices in chronic care treatment plans.
   
• Additionally, manufacturers are now offering ultra-fine short needles and other advanced needle technologies that reduce the pain and trauma of injections. Needles without permanent tips are gaining popularity because they lower the risk of needlestick injuries. These innovations have improved patient compliance and healthcare provider safety, boosting demand for these needles and, consequently, increasing their market share.
   

Based on usability, the hypodermic syringes and needles market is bifurcated as disposable and reusable. The disposable segment is expected to drive business growth and expand at a CAGR of 3%, reaching over USD 9.7 billion by 2034.
 

• Through a comprehensive analysis of data chest bound in the year 2021, about 43% of physicians were using single-use syringes and needles, and this has tremendously aided in preventing the spread of disease. Disposable syringes and needles are unique and one of a kind because they serve the purpose of self-injection while maximizing efficiency. Their utility has helped various healthcare centers significantly reduce hospital-acquired infections or HAIs.
   
• These devices have claimed the spotlight, capturing the attention of numerous global ratification bodies and public health industries. The speech placed emphasis on the greater concern of health safety along with other WHO recommendations. The use of single-patient syringes is mandated as the devices otherwise pose the risk of being reused and subsequently contaminated. Such rules support greater service by posing stern rules and restrictions on utilization.
   

Based on application, the hypodermic syringes and needles market is bifurcated as blood collection, drug delivery, vaccination, insulin administration, and other applications. The drug delivery segment is expected to drive business growth and expand at a CAGR of 2.8%, reaching over USD 4.8 billion by 2034.
 

• Getting deep into the skin is very important while administering medications for chronic ailments, caring for pain relief, performing vaccinations, and other purposes. This segment is the largest when it comes to therapy as a result of increasing incidences of chronic illnesses as well as the need for refined and efficient methods of administering medications.
   
• On top of that, there is an expanding global epidemiology of persistent diseases like diabetes, arthritis, and heart disease, which makes the use of hypodermic syringes and needles ever-increasing. Those having chronic ailments will need sustained injections, even at times on a daily basis, and thus, it becomes critical in the primary healthcare setting. For example, patients who are undergoing treatment for diabetes have to depend greatly on injections, and this increases the demand for this segment and further reinforces the stability of the market. 
   

Based on end use, the hypodermic syringes and needles market is classified into hospitals, ambulatory surgical centers, multi-specialty centers, clinics, and other end users. The hospitals segment dominated the market with a revenue share of 60.2% in 2024.
 

• These institutions incorporate new technologies and complex surgeries and procedures are done by qualified personnel. Hospitals usually serve as the first places where implant surgeries are done and these specialized departments also include cardiology orthopedics and neurosurgery. This specialization and the various intricate medical procedures they carry out mean that hospitals need a lot of hypodermic syringes and needles.
   
• In addition, the hospital category leads in sales of represented hypodermic syringes and needles because these hospitals have sophisticated equipment, well-trained personnel, and a large number of operations performed. The high volumetric usage of medical supplies contributes to the dominating position of hospitals in the market for hypodermic syringes and needles. 
   

U.S. hypodermic syringes and needles market accounted for USD 2.07 billion in 2023 and USD 2.13 billion in 2024 and is anticipated to grow at a CAGR of 1.8% between 2025 to 2034 period.
 

• The healthcare infrastructure in the U.S. is highly developed, with a high prevalence of chronic diseases, which, along with a compelling demand for injectable treatment, boosts its market share in hypodermic syringes and needles.
   
• Additionally, the U.S. has a large population of people with diabetes who frequently need insulin injections. This has led to a substantial demand for precise and dependable syringes and needles.
   
• Additionally, the presence of the FDA and its rigorous quality and safety standards has positioned the U.S. as a leader in healthcare innovation and regulation.
   

In the Europe hypodermic syringes and needles market, France is projected to grow remarkably in the coming years.
 

• The nation places great emphasis on preventive healthcare through public health campaigns advocating for vaccination and immunization as well. The France medical device manufacturing industry also boosts the market by supplying high-quality, locally produced syringes and needles.
   
• In addition, the French stronghold on the market is further bolstered by the aging population and increased prevalence of chronic diseases, including diabetes and arthritis, that also increase the requirement for frequent injections. 
   

Japan holds a dominant position in the Asia Pacific hypodermic syringes and needles market.
 

• At the forefront of medical technology and healthcare innovation is Japan, whose advanced hypodermic devices aim to maximize patient safety and comfort.
   
• The use of disposable syringes and needles is prevalent in Japan, as the country’s healthcare system places great importance on infection control.
   
• Japan’s market for hypodermic syringes and needles is also growing because of the country’s proactive stance on public health and vaccination programs, alongside other preventive healthcare measures.
   

Hypodermic Syringes and Needles Market Share

The top five companies, namely Abbott, B. Braun, BD (Becton, Dickinson and Company), Cardinal Health, and DeRoyal hold a 30% market share in the market. The market is experiencing growth due to the involvement of various international and national stakeholders. Several factors contribute to shifts in market share, including innovation, the granting of new patents, industry mergers and acquisitions, and the development of safer, more efficient materials. Established firms dominate this market by prioritizing advancements in technology and product quality.
 

The interplay between established companies and emerging biotech startups fosters a competitive environment where both product and price competitiveness are key. Additionally, the adoption of hypodermic syringes and needles is supported by collaborations between medical device manufacturers and healthcare institutions, which further enhance marketing efforts. The increasing demand driven by aging populations and the growing prevalence of chronic diseases continues to drive market expansion. The market also sees frequent mergers, geographical expansion, and continuous development of new product versions.
 

Hypodermic Syringes and Needles Market Companies

Prominent players operating in the hypodermic syringes and needles industry include:

• Abbott
• B. Braun
• BD (Becton, Dickinson and Company)
• Cardinal Health
• Catalent
• Connecticut Hypodermics
• DeRoyal
• EXEl
• HI-TECH MEDICS
• ICU medical
• Lifelong MEDITECH
• McKESSON
• Medline
• NIPRO
• RETRACTABLE TECHNOLOGIES
• TERUMO
• VITA NEEDLE
• VMG
   
• Abbott – Abbott focuses on researching, developing, and selling drugs, nutritional products, and medical devices. Their commitment to innovation and resolving health issues around the globe makes them a dependable partner in healthcare.
   
• B. Braun – B. Braun is known for its advanced medical products and solutions such as surgical sutures and IV containers. They are a leader in providing innovative medical technology that ensures patient safety and quality, making them a trusted partner in healthcare.
   

Hypodermic Syringes and Needles Industry News:

• In January 2022, ICU Medical completed the acquisition of Smiths Medical, creating a leading infusion therapy company. This acquisition enabled the company to provide infusion therapy services and products using devices such as ambulatory infusion, syringes, and other catheters, which made the company an industry leader.
   
• In June 2021, Terumo Pharmaceutical Solutions introduced a new innovation focused on combining simpler forms of parenteral therapeutic administration with injection technologies without exposing practitioners to needlestick injuries. These products improved the company’s portfolio and provided a superior position in the market.
   

The hypodermic syringes and needles market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Syringes
• Needles

Market, By Usability

• Disposable
• Reusable

Market, By Application

• Blood collection
• Drug delivery
• Vaccination
• Insulin administration
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Diagnostic centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE